Ascribe develops natural crop protection products that assist farmers in reducing disease and increasing yields without harming human health or the environment. Its products are based on naturally-occuring small molecules from soil microbiomes that are safe, flexible to fit modern operations, and produce real results in the field. Ascribe’s technology is a proprietary discovery platform that applies metabolomics tools to soil microbiomes to identify small molecules that mediate beneficial interactions between the crops and soil. Its lead product is Phytilax, which acts like a vaccine for plants, and is nontoxic, biodegradable, and non-GMO. Ascribe is a privately held company.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.